Cargando…

A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio

BACKGROUND: Oxidation and inflammation play significant roles in the pathogenesis of coronary artery diseases. Monocyte count to high-density lipoprotein (HDL) cholesterol ratio (MHR) is a new marker and has revealed as an indicator of inflammation in the literature. The present study aimed to searc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ucar, Fatih Mehmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048646/ https://www.ncbi.nlm.nih.gov/pubmed/27716070 http://dx.doi.org/10.1186/s12872-016-0367-3

Ejemplares similares

Association of monocyte to high-density lipoprotein ratio with bare-metal stent restenosis in STEMI patients treated with primary PCI
por: Avci, Ilhan Ilker, et al.
Publicado: (2018)

Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis
por: Canpolat, Uğur, et al.
Publicado: (2016)

The Predictive Value of Monocyte Count to High-Density Lipoprotein Cholesterol Ratio in Restenosis After Drug-Eluting Stent Implantation
por: Nan, Jing, et al.
Publicado: (2020)

Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
por: Sirin, Mumtaz Cem, et al.
Publicado: (2020)

The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome
por: Usta, Akin, et al.
Publicado: (2018)

Monocyte-to-HDL-cholesterol ratio is associated with Ascending Aorta Dilatation in Patients with Bicuspid Aortic Valve
por: Acar, Burak, et al.
Publicado: (2021)

Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
por: Bilik, Mehmet Zihni, et al.
Publicado: (2022)

Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia
por: Kılıç, Nülüfer, et al.
Publicado: (2023)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Coronary Angioscopy Findings before and after Excimer Laser Coronary Angioplasty for Bare-Metal Stent In-Stent Restenosis
por: Masuda, Shinichiro, et al.
Publicado: (2019)

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent
por: Bagyura, Zsolt, et al.
Publicado: (2017)

A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio
por: Ekizler, Firdevs Aysenur, et al.
Publicado: (2019)

A New Inflammatory Marker: Elevated Monocyte to HDL Cholesterol Ratio Associated with Smoking
por: Yılmaz, Mücahid, et al.
Publicado: (2018)

Monocyte-to-HDL ratio and non-HDL cholesterol were predictors of septic shock in newborns
por: da Fonseca, Fernanda Andrade Macaferri, et al.
Publicado: (2022)

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis
por: Pleva, Leos, et al.
Publicado: (2017)

Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment
por: Gouveia, Viviane, et al.
Publicado: (2016)

Elevated monocyte-to-HDL cholesterol ratio predicts post-stroke depression
por: Li, Yaqiang, et al.
Publicado: (2022)

Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease
por: Chen, Bo-Wen, et al.
Publicado: (2022)

Monocyte to HDL cholesterol ratio as a marker of the presence and severity of obstructive sleep apnea in hypertensive patients
por: Sun, Min, et al.
Publicado: (2021)

Cadmium Exposure Is Associated with Monocyte Count and Monocyte to HDL Ratio, a Marker of Inflammation and Future Cardiovascular Disease in the Male Population
por: Baek, Kiook, et al.
Publicado: (2017)

Monocyte to HDL and Neutrophil to HDL Ratios as Potential Ischemic Stroke Prognostic Biomarkers
por: Gkantzios, Aimilios, et al.
Publicado: (2023)

Mechanical and Histopathological Comparison between Commercialized and Newly Designed Coronary Bare Metal Stents in a Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2013)

Relation Between the Novel Marker Monocyte to High-Density Lipoprotein Cholesterol Ratio and Severity in Multiple Sclerosis
por: Ulusoy, Ersin Kasım, et al.
Publicado: (2020)

Hybrid surgery techniques for the treatment of in-stent restenosis after 5 years of femoral artery self-expanding bare-metal stent implantation: A case report
por: Zhou, Jianguo, et al.
Publicado: (2022)

Very Late Bare Metal Stent Thrombosis
por: Soto Herrera, Mariana, et al.
Publicado: (2013)

Bare-metal stent thrombosis two decades after stenting
por: Acibuca, Aynur, et al.
Publicado: (2015)

Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
por: Wang, Dianhui, et al.
Publicado: (2018)

The Ratio of Monocytes to HDL-Cholesterol Is Associated with Cardiovascular Risk and Insulin Resistance in Patients with Rheumatoid Arthritis
por: Romo-Cordero, Alejandro, et al.
Publicado: (2023)

Efficacy of intramuscular methyl prednisolone in preventing restenosis after coronary artery stenting with bare-metal stainless steel stent: a double-blind, randomised, controlled clinical trial
por: Namdari, M, et al.
Publicado: (2011)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

New prognostic factor for hepatitis B virus‐related decompensated cirrhosis: Ratio of monocytes to HDL‐cholesterol
por: Wu, Qianxia, et al.
Publicado: (2021)

Exploring alternatives to drug-eluting stents: the potential of combining drug coated balloon with bare-metal stents
por: Murai, Kota, et al.
Publicado: (2023)

Severe In-stent Calcification in a 17-year-old Bare-metal Stent
por: Kudo, Akihito, et al.
Publicado: (2019)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
por: Maciejewski, Damian R., et al.
Publicado: (2019)

Clinical and Angiographic Outcomes after Intracoronary Bare-Metal Stenting
por: Hsieh, I-Chang, et al.
Publicado: (2014)

Long term outcomes after bare metal stent implantation
por: Harikrishnan, S., et al.
Publicado: (2021)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

Liquid Metal-Based Flexible Bioelectrodes for Management of In-Stent-Restenosis: Potential Application
por: Zhang, Xilong, et al.
Publicado: (2023)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
por: Luo, Yinhua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kjanpi4e0vdr45u658rvn66lif